Cardiovascular Systems to Webcast Fiscal 2010 Third-Quarter Earnings Conference Call Wednesday, May 5
April 28 2010 - 12:00PM
Business Wire
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a
live webcast of its fiscal 2010 third-quarter conference call on
Wednesday, May 5, 2010, at 3:45 p.m. CT (4:45 p.m. ET). David L.
Martin, president and chief executive officer, and Laurence L.
Betterley, chief financial officer, will discuss the company’s
results for its fiscal third quarter ended March 31, 2010, and its
financial outlook. The company will issue a post-market earnings
release on May 5.
To access the live webcast, go to the investor information
section of the company’s website, www.csi360.com, on the day of the
conference call and click on the webcast icon. A webcast replay
will be available beginning at 7 p.m. CT the same day.
To participate in the conference call, dial (888) 713-4209 and
enter 71236627. Please dial in at least 10 minutes prior to the
call. To pre-register for the call, log on to the following
website:
https://www.theconferencingservice.com/prereg/key.process?key=P44YXDQ36.
When joining the call, pre-registered participants can enter their
PIN code, and other participants can wait for operator
assistance.
If you do not have access to the Internet and want to listen to
an audio replay of the conference call, dial (888) 286-8010 and
enter access number 35324704. The audio replay will be available
beginning at 8 p.m. CT on Wednesday, May 5, 2010, through 6 p.m. CT
on Friday, May 7, 2010.
About Cardiovascular Systems, Inc.
Cardiovascular Systems Inc., (CSI) (Nasdaq: CSII) based in St.
Paul, Minn., is a medical device company focused on providing
clinically proven, safe and effective interventional solutions for
vascular disease. The company’s Diamondback 360® PAD System removes
calcified and fibrotic plaque in small and large peripheral
vessels, and addresses many of the limitations associated with
existing surgical, catheter and pharmacological treatment
alternatives. In August 2007, the U.S. FDA granted 510(k) clearance
for the use of the Diamondback 360° as a therapy for PAD, and CSI
commenced a U.S. product launch in September 2007. Since then, more
than 25,000 procedures have been performed using the system. For
more information visit the company’s website at www.csi360.com.
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From May 2024 to Jun 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2023 to Jun 2024